Finance and efficiency

Cancer drugs fund threatens NHS England's bottom line

By and 2014-11-05T00:01:00

Paul Baumann

The NHS commissioning system is forecast to miss its target surplus by £184m in 2014-15, with much of the overspend attributed to the cancer drugs fund

You need to be a subscriber to read more

HSJ

Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

  • All HSJ news by sector, topic & region
  • Breaking News announcements
  • App for mobile and offline reading
  • Comment and Daily Insights newsletters
  • Regional roundup newsletters
  • Unrestricted access to ‘Ask HSJ’ - AI assistant - AI assistant
  • 10 expert briefings every fortnight (Premium only)

Subscribe

to HSJ

Already a subscriber? Sign into your account here